[PDF] Top 20 BORDA, GUILLERMO CONCEPTO DE LEY DE ORDEN PÚBLICO
Has 10000 "BORDA, GUILLERMO CONCEPTO DE LEY DE ORDEN PÚBLICO" found on our website. Below are the top 20 most common "BORDA, GUILLERMO CONCEPTO DE LEY DE ORDEN PÚBLICO".
A novel method for finding non-small cell lung cancer diagnosis biomarkers
... We presented a method that can find cost-effective biolo- gical markers as quantifiable measurements for an almost perfect predictive accuracy of NSCLC lung cancers. As cancers are complicated, one can only ... See full document
24
Clinical Biomarkers and Prognosis in Taiwanese Patients with Non Small Cell Lung Cancer (NSCLC)
... Introduction: Lung cancer is the leading cause of cancer death worldwide with poor survival ...with lung cancer are not ...laboratory biomarkers and traditional factors on ... See full document
15
Enriched sera protein profiling for detection of non-small cell lung cancer biomarkers
... potential biomarkers for the diagnosis of some types of cancer, such as ovarian [8,9], breast [10,11], col- orectal [12], and prostate cancer [13,14], as well as for many other diseases ... See full document
11
Cetuximab and biomarkers in non-small-cell lung carcinoma
... molecular cancer research and the several clinical trials that have evaluated cetuximab in the context of NSCLC, no clear significant biomarker has so far been ...potential biomarkers are by no means ... See full document
26
Expression of Two Basic mRNA Biomarkers in Peripheral Blood of Patients with Non-Small Cell Lung Cancer Detected by Real-Time RT-PCR, Individually and Simultaneously
... qRT-PCR method, this gene can also be considered as a reference in this ...NSCLC cancer patients through qRT-PCR and to study their sensitivity and specificity individually and in combined ...applicable ... See full document
9
Combined detection of dickkopf-1 subtype classification autoantibodies as biomarkers for the diagnosis and prognosis of non-small cell lung cancer
... Experimental design: Epitope mapping by peptide microarray-based serum screening of NSCLC patients (n=72) and healthy controls (n=16) was performed. Indirect ELISA with peptides was used to measure the serum levels of ... See full document
19
<p>Clinical utility of a novel natural killer cell activity assay for diagnosing non-small cell lung cancer: a prospective pilot study</p>
... early lung cancer. However, NKA could be used as a surveillance method after systemic treatment in advanced diseases because compromised NKA implies evasion of anti- tumor immune response and ... See full document
7
Exploration of Serum Exosomal LncRNA TBILA and AGAP2-AS1 as Promising Biomarkers for Diagnosis of Non-Small Cell Lung Cancer
... Non-small cell lung cancer is the most common type of cancer with a poor prognosis, and development of an effective diagnostic method is urgently ...promising ... See full document
67
Identification and validation of the methylation biomarkers of non-small cell lung cancer (NSCLC)
... candidate biomarkers have been investigated widely in cancer ...carcinogenesis, cancer progression [21] and prog- nosis ...for cancer progression and as a component of personalized medicine in ... See full document
136
<p>Identification of novel biomarkers and candidate small molecule drugs in non-small-cell lung cancer by integrated microarray analysis</p>
... potential small molecule drugs for use in patients based on the gene signature of ...various small molecular ...ing small molecule is able to induce the state of NSCLC cells, whereas a negative ... See full document
28
HSP90 as a novel molecular target in non-small-cell lung cancer
... Lung Cancer: Targets and Therapy is an international, peer-reviewed, open access journal focusing on lung cancer research, identification of therapeutic targets and the optimal use of ... See full document
12
Altered phosphatidylcholines expression in sputum for diagnosis of non–small cell lung cancer
... PCA is the statistical tool used to explain differentiation between samples and to obtain more information on the variables that mainly influence sample similarities and differences. This procedure extracts the dominant ... See full document
15
Original Article ELMO3 is a novel biomarker for diagnosis and prognosis of non-small cell lung cancer
... Lung cancer is a major cause of cancer-related death in worldwide, accounting for 18% ...of cancer deaths in 2008 according to global cancer statistics ...subtypes, small ... See full document
11
Biomarkers for early diagnosis, prognosis, prediction, and recurrence monitoring of non-small cell lung cancer
... automated method for subsequent assessment of the retained cells, and standardized pipeline for sequencing data analysis before clinical implementation in ... See full document
8
Identification of tumor-educated platelet biomarkers of non-small-cell lung cancer
... of lung cancer is critical for NSCLC patients, since early-stage patients have much longer survival than late-stage ...conventional lung cancer screening, such as chest X-rays, sputum ... See full document
15
<p>Characterization of acquired receptor tyrosine–kinase fusions as mechanisms of resistance to EGFR tyrosine–kinase inhibitors</p>
... Methods: We retrospectively reviewed genomic pro fi ling data of 3873 EGFR (exons 18 – 21)-mutant lung cancer patients with more than once next-generation sequencing detection. A total of 16 patients who ... See full document
100
Prognostic value of metformin for non small cell lung cancer patients with diabetes
... rapamycin, cell cycle, inflammation, glucose metabolism, angiogenesis, and cancer stem cells, metformin plays its possible anti- cancer role; among them, the AMPK activation is believed to mediate ... See full document
31
Novel classes of non coding RNAs and cancer
... germ cell development, stem cell self- renewal, and retrotransposon ...colorectal cancer [83], gli- omas [84] and esophageal squamous cell carcinomas ...gastric cancer tissues was ... See full document
10
Surgical treatment in non small cell lung cancer with pulmonary oligometastasis
... Primary lung cancer is one of the most common malig- nant tumors and is still the leading cause of cancer- related death in many countries [1, ...of lung cancer is increasing every ... See full document
26
Journal of Applied Pharmaceutical Science
... against non-small cell lung carcinoma (A549) cell line using MTX (X) as a reference ...A549 cell line was widely used as in vitro model for type II pulmonary epithelial ... See full document
7
Related subjects